Establishment of Imatinib-Resistant Gastrointestinal Stromal Tumor Cell Subline and Investigation of Its Sensitivity to the Chemomotherapeutic Agents

Kazan medical journal
doi 10.17750/kmj2017-993
Full Text
Abstract

Available in full text

Date
Authors
Publisher

ECO-Vector LLC

Related search

RACK1 Overexpression Is Linked to Acquired Imatinib Resistance in Gastrointestinal Stromal Tumor

Oncotarget
Oncology
2016English

Insulin-Like Growth Factor Binding Protein-3 Has Dual Effects on Gastrointestinal Stromal Tumor Cell Viability and Sensitivity to the Anti-Tumor Effects of Imatinib Mesylate in Vitro

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2009English

Crenolanib Inhibits the Drug-Resistant PDGFRA D842V Mutation Associated With Imatinib-Resistant Gastrointestinal Stromal Tumors

Clinical Cancer Research
Cancer ResearchOncology
2012English

Histone H2AX Is a Mediator of Gastrointestinal Stromal Tumor Cell Apoptosis Following Treatment With Imatinib Mesylate

Cancer Research
Cancer ResearchOncology
2007English

Sunitinib Malate for Gastrointestinal Stromal Tumour in Imatinib Mesylate–resistant Patients: Recommendations and Evidence

Current Oncology
Oncology
2010English

Severe Esophagitis in a Patient With Gastrointestinal Stromal Tumor Treated With Imatinib

Endoscopy
Gastroenterology
2009English

Gastrointestinal Stromal Tumor of the Duodenum

Novosti Khirurgii
Surgery
2013English

Imatinib Induced Severe Skin Reactions and Neutropenia in a Patient With Gastrointestinal Stromal Tumor

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

Genome-Scale CRISPR-Cas9 Knockout Screening in Gastrointestinal Stromal Tumor With Imatinib Resistance

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy